In the current study, we identified that Y‐box binding protein 1 (YBX1) is considerably upregulated in most paediatric AML patient‐derived sEVs compared to healthy controls, and their expression level is independent of AML subtype. Here, YBX1 is linked to acute myeloid leukemia.